Stem-cell based therapy shows promise in treating high-risk type 1 diabetes - EurekAlert
6/11/2022 12:00:00 AM2 years 11 months ago
An investigative stem cell-based therapy called PEC-Direct, designed to act as a replacement pancreas, has the potential to provide blood sugar control in patients with high-risk type 1 diabetes, suggests a clinical study presented Saturday, June 11 at ENDO 2…
An investigative stem cell-based therapy called PEC-Direct, designed to act as a replacement pancreas, has the potential to provide blood sugar control in patients with high-risk type 1 diabetes, sug… [+3763 chars]
full article...